Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.25% | $21.63M | €413.15B | 48.58% | 76 Outperform | |
| Roche Holding AG | 1.40% | $13.51M | CHF272.24B | 45.48% | 73 Outperform | |
| AstraZeneca | 1.34% | $12.92M | £220.41B | 29.45% | 80 Outperform | |
| HSBC Holdings | 1.30% | $12.50M | £205.11B | 49.44% | 80 Outperform | |
| Novartis AG | 1.27% | $12.22M | CHF217.04B | 25.19% | 80 Outperform | |
| SAP SE | 1.19% | $11.44M | €241.78B | -14.21% | 66 Neutral | |
| Nestlé SA | 1.14% | $10.95M | CHF190.59B | 15.67% | 71 Outperform | |
| Toyota Motor | 1.06% | $10.23M | ¥44.16T | 14.07% | 80 Outperform | |
| Siemens | 1.03% | $9.90M | €198.34B | 29.64% | 74 Outperform | |
| Shell (UK) | 0.97% | $9.29M | £150.06B | 0.57% | 73 Outperform |